Novel motif:68: Difference between revisions
From FANTOM5_SSTAR
(Created page with "{{Novel_motif
|name=motif68_CTTTTAAAC
|novel_motifs_human_sample_pval=11376-118A8_11051;0.515568,11327-117E4_11969;0.3028,11473-119C6_11054;0.91555,11474-119C7_12067;0.20443...") |
No edit summary |
||
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 14:52, 9 September 2013
name: | motif68_CTTTTAAAC |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0048521 | negative regulation of behavior | 1.688558e-9 |
GO:0050922 | negative regulation of chemotaxis | 5.112311e-9 |
GO:0051090 | regulation of sequence-specific DNA binding transcription factor activity | 6.579890e-8 |
GO:0010633 | negative regulation of epithelial cell migration | 7.012452e-8 |
GO:0030517 | negative regulation of axon extension | 7.035733e-8 |
GO:0048843 | negative regulation of axon extension involved in axon guidance | 1.166533e-7 |
GO:0051091 | positive regulation of sequence-specific DNA binding transcription factor activity | 2.682305e-7 |
GO:0043420 | anthranilate metabolic process | 2.951500e-7 |
GO:0034516 | response to vitamin B6 | 2.951500e-7 |
GO:0045927 | positive regulation of growth | 3.556223e-7 |
GO:0008152 | metabolic process | 4.083631e-7 |
GO:0019442 | tryptophan catabolic process to acetyl-CoA | 4.634733e-7 |
GO:0018874 | benzoate metabolic process | 5.751161e-7 |
GO:0015711 | organic anion transport | 6.002017e-7 |
GO:0042938 | dipeptide transport | 6.499160e-7 |
GO:0008406 | gonad development | 1.088106e-6 |
GO:0048640 | negative regulation of developmental growth | 1.167337e-6 |
GO:0048880 | sensory system development | 1.285717e-6 |
GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 1.452242e-6 |
GO:0019441 | tryptophan catabolic process to kynurenine | 1.472949e-6 |
GO:0046620 | regulation of organ growth | 1.531406e-6 |
GO:0006003 | fructose 2,6-bisphosphate metabolic process | 1.966641e-6 |
GO:0000082 | G1/S transition of mitotic cell cycle | 2.554189e-6 |
GO:0040008 | regulation of growth | 2.601220e-6 |
GO:0007042 | lysosomal lumen acidification | 2.713323e-6 |
GO:0070189 | kynurenine metabolic process | 3.120937e-6 |
GO:0048841 | regulation of axon extension involved in axon guidance | 3.516926e-6 |
GO:0032787 | monocarboxylic acid metabolic process | 3.965053e-6 |
GO:0045730 | respiratory burst | 4.073664e-6 |
GO:0030522 | intracellular receptor mediated signaling pathway | 4.074026e-6 |
GO:0045137 | development of primary sexual characteristics | 4.199543e-6 |
GO:0008610 | lipid biosynthetic process | 5.579340e-6 |
GO:0060445 | branching involved in salivary gland morphogenesis | 5.752930e-6 |
GO:0031658 | negative regulation of cyclin-dependent protein kinase activity involved in G1/S | 6.203891e-6 |
GO:0007092 | activation of mitotic anaphase-promoting complex activity | 6.203891e-6 |
GO:0050919 | negative chemotaxis | 6.793384e-6 |
GO:0043066 | negative regulation of apoptosis | 8.326444e-6 |
GO:0044238 | primary metabolic process | 8.722518e-6 |
GO:0021847 | ventricular zone neuroblast division | 9.343134e-6 |
GO:0006420 | arginyl-tRNA aminoacylation | 1.041316e-5 |
GO:0043392 | negative regulation of DNA binding | 1.049435e-5 |
GO:0048608 | reproductive structure development | 1.132026e-5 |
GO:0034198 | cellular response to amino acid starvation | 1.187978e-5 |
GO:0006950 | response to stress | 1.196255e-5 |
GO:0032119 | sequestering of zinc ion | 1.551248e-5 |
GO:0006097 | glyoxylate cycle | 1.555271e-5 |
GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching | 1.620526e-5 |
GO:0060068 | vagina development | 1.693745e-5 |
GO:0031663 | lipopolysaccharide-mediated signaling pathway | 1.760633e-5 |
GO:0043069 | negative regulation of programmed cell death | 1.814332e-5 |
GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle | 1.947541e-5 |
GO:0043252 | sodium-independent organic anion transport | 2.064073e-5 |
GO:0006916 | anti-apoptosis | 2.170404e-5 |
GO:0009789 | positive regulation of abscisic acid mediated signaling pathway | 2.531819e-5 |
GO:0072520 | seminiferous tubule development | 2.658239e-5 |
GO:0009072 | aromatic amino acid family metabolic process | 2.807975e-5 |
GO:0000077 | DNA damage checkpoint | 2.839640e-5 |
GO:0031323 | regulation of cellular metabolic process | 2.887228e-5 |
GO:0060548 | negative regulation of cell death | 3.316860e-5 |
GO:0033211 | adiponectin-mediated signaling pathway | 3.325447e-5 |
GO:0003401 | axis elongation | 3.443920e-5 |
GO:0051252 | regulation of RNA metabolic process | 3.549285e-5 |
GO:0042221 | response to chemical stimulus | 3.631766e-5 |
GO:0051488 | activation of anaphase-promoting complex activity | 3.925146e-5 |
GO:0060600 | dichotomous subdivision of an epithelial terminal unit | 4.007250e-5 |
GO:0006796 | phosphate-containing compound metabolic process | 4.154776e-5 |
GO:0060255 | regulation of macromolecule metabolic process | 4.277979e-5 |
GO:0006857 | oligopeptide transport | 4.358101e-5 |
GO:0035335 | peptidyl-tyrosine dephosphorylation | 4.749263e-5 |
GO:0019805 | quinolinate biosynthetic process | 4.880585e-5 |
GO:0030183 | B cell differentiation | 4.951008e-5 |
GO:0031570 | DNA integrity checkpoint | 4.978437e-5 |
GO:0044237 | cellular metabolic process | 5.421963e-5 |
GO:0019752 | carboxylic acid metabolic process | 5.578704e-5 |
GO:0010621 | negative regulation of transcription by transcription factor localization | 5.763711e-5 |
GO:0048769 | sarcomerogenesis | 6.027932e-5 |
GO:0048483 | autonomic nervous system development | 6.475308e-5 |
GO:0055008 | cardiac muscle tissue morphogenesis | 6.618048e-5 |
GO:0060008 | Sertoli cell differentiation | 6.725390e-5 |
GO:0042180 | cellular ketone metabolic process | 6.876421e-5 |
GO:0080090 | regulation of primary metabolic process | 7.036708e-5 |
GO:0030098 | lymphocyte differentiation | 7.278371e-5 |
GO:0032989 | cellular component morphogenesis | 7.492069e-5 |
GO:2000602 | regulation of interphase of mitotic cell cycle | 7.821024e-5 |
GO:0046622 | positive regulation of organ growth | 7.889641e-5 |
GO:0001932 | regulation of protein phosphorylation | 7.935829e-5 |
GO:0060602 | branch elongation of an epithelium | 7.960729e-5 |
GO:0046487 | glyoxylate metabolic process | 8.355663e-5 |
GO:0022602 | ovulation cycle process | 8.359473e-5 |
GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway | 8.435386e-5 |
GO:0019220 | regulation of phosphate metabolic process | 8.512772e-5 |
GO:0006569 | tryptophan catabolic process | 8.800311e-5 |
GO:0070253 | somatostatin secretion | 9.045312e-5 |
GO:0032812 | positive regulation of epinephrine secretion | 9.045312e-5 |
GO:0007399 | nervous system development | 9.214879e-5 |
GO:0006568 | tryptophan metabolic process | 9.453823e-5 |
GO:0042698 | ovulation cycle | 1.000418e-4 |
GO:0060464 | lung lobe formation | 1.023026e-4 |
GO:0043170 | macromolecule metabolic process | 1.075368e-4 |
GO:0030574 | collagen catabolic process | 1.127284e-4 |
GO:0008584 | male gonad development | 1.134258e-4 |
GO:0006082 | organic acid metabolic process | 1.309858e-4 |
GO:0000070 | mitotic sister chromatid segregation | 1.336856e-4 |
GO:0007548 | sex differentiation | 1.339441e-4 |
GO:0043412 | macromolecule modification | 1.356171e-4 |
GO:0046874 | quinolinate metabolic process | 1.370564e-4 |
GO:0016540 | protein autoprocessing | 1.377095e-4 |
GO:0009409 | response to cold | 1.392403e-4 |
GO:0030321 | transepithelial chloride transport | 1.402242e-4 |
GO:0071526 | semaphorin-plexin signaling pathway | 1.431887e-4 |
GO:0006629 | lipid metabolic process | 1.461351e-4 |
GO:0014706 | striated muscle tissue development | 1.532589e-4 |
GO:0006464 | protein modification process | 1.548056e-4 |
GO:0002331 | pre-B cell allelic exclusion | 1.579441e-4 |
GO:0060415 | muscle tissue morphogenesis | 1.585384e-4 |
GO:0002028 | regulation of sodium ion transport | 1.601767e-4 |
GO:0021869 | forebrain ventricular zone progenitor cell division | 1.622370e-4 |
GO:0021873 | forebrain neuroblast division | 1.636784e-4 |
GO:0048738 | cardiac muscle tissue development | 1.702838e-4 |
GO:0002237 | response to molecule of bacterial origin | 1.726933e-4 |
GO:0006583 | melanin biosynthetic process from tyrosine | 1.764477e-4 |
GO:0000278 | mitotic cell cycle | 1.806375e-4 |
GO:0006102 | isocitrate metabolic process | 1.943894e-4 |
GO:0000819 | sister chromatid segregation | 2.032319e-4 |
GO:0010564 | regulation of cell cycle process | 2.086362e-4 |
GO:0042402 | cellular biogenic amine catabolic process | 2.130084e-4 |
GO:0019538 | protein metabolic process | 2.184996e-4 |
GO:0031399 | regulation of protein modification process | 2.319642e-4 |
GO:0046546 | development of primary male sexual characteristics | 2.327824e-4 |
GO:0009617 | response to bacterium | 2.380395e-4 |
GO:0031346 | positive regulation of cell projection organization | 2.572330e-4 |
GO:0006468 | protein phosphorylation | 2.627480e-4 |
GO:0007435 | salivary gland morphogenesis | 2.658778e-4 |
GO:0060601 | lateral sprouting from an epithelium | 2.670263e-4 |
GO:0010632 | regulation of epithelial cell migration | 2.684672e-4 |
GO:0046496 | nicotinamide nucleotide metabolic process | 2.711514e-4 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 2.731901e-4 |
GO:0071436 | sodium ion export | 2.784782e-4 |
GO:0060411 | cardiac septum morphogenesis | 2.848665e-4 |
GO:0016311 | dephosphorylation | 2.873275e-4 |
GO:0010463 | mesenchymal cell proliferation | 2.887809e-4 |
GO:0046661 | male sex differentiation | 2.914719e-4 |
GO:0002335 | mature B cell differentiation | 2.951704e-4 |
GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway | 2.965699e-4 |
GO:0045017 | glycerolipid biosynthetic process | 3.019242e-4 |
GO:0070417 | cellular response to cold | 3.050896e-4 |
GO:0001541 | ovarian follicle development | 3.131959e-4 |
GO:0050851 | antigen receptor-mediated signaling pathway | 3.137332e-4 |
GO:0042113 | B cell activation | 3.227599e-4 |
GO:0006663 | platelet activating factor biosynthetic process | 3.308091e-4 |
GO:0001558 | regulation of cell growth | 3.320030e-4 |
GO:0006470 | protein dephosphorylation | 3.349346e-4 |
GO:0060737 | prostate gland morphogenetic growth | 3.404609e-4 |
GO:0090304 | nucleic acid metabolic process | 3.428088e-4 |
GO:0055003 | cardiac myofibril assembly | 3.476581e-4 |
GO:0035054 | embryonic heart tube anterior/posterior pattern specification | 3.562744e-4 |
GO:0000075 | cell cycle checkpoint | 3.677622e-4 |
GO:0051726 | regulation of cell cycle | 3.731769e-4 |
GO:0046208 | spermine catabolic process | 3.763267e-4 |
GO:0006084 | acetyl-CoA metabolic process | 3.766544e-4 |
GO:0002768 | immune response-regulating cell surface receptor signaling pathway | 3.782179e-4 |
GO:0051100 | negative regulation of binding | 3.918617e-4 |
GO:0030308 | negative regulation of cell growth | 3.956326e-4 |
GO:0007076 | mitotic chromosome condensation | 3.967863e-4 |
GO:0042345 | regulation of NF-kappaB import into nucleus | 4.058376e-4 |
GO:0031344 | regulation of cell projection organization | 4.195290e-4 |
GO:0019439 | aromatic compound catabolic process | 4.259858e-4 |
GO:0003290 | atrial septum secundum morphogenesis | 4.301335e-4 |
GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis | 4.353960e-4 |
GO:0048644 | muscle organ morphogenesis | 4.407839e-4 |
GO:0009074 | aromatic amino acid family catabolic process | 4.414992e-4 |
GO:0006355 | regulation of transcription, DNA-dependent | 4.451220e-4 |
GO:0042325 | regulation of phosphorylation | 4.504136e-4 |
GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway | 4.590439e-4 |
GO:0040018 | positive regulation of multicellular organism growth | 4.639559e-4 |
GO:0032102 | negative regulation of response to external stimulus | 4.656895e-4 |
GO:0035265 | organ growth | 4.811189e-4 |
GO:0006814 | sodium ion transport | 4.825218e-4 |
GO:0060045 | positive regulation of cardiac muscle cell proliferation | 4.872564e-4 |
GO:0055007 | cardiac muscle cell differentiation | 4.954619e-4 |
GO:0007417 | central nervous system development | 4.976903e-4 |
GO:0035051 | cardiac cell differentiation | 4.982259e-4 |
GO:0044106 | cellular amine metabolic process | 5.074269e-4 |
GO:0009310 | amine catabolic process | 5.086478e-4 |
GO:0045778 | positive regulation of ossification | 5.168395e-4 |
GO:0051351 | positive regulation of ligase activity | 5.386679e-4 |
GO:0033032 | regulation of myeloid cell apoptosis | 5.541272e-4 |
GO:0035845 | photoreceptor cell outer segment organization | 5.572936e-4 |
GO:0048856 | anatomical structure development | 5.617554e-4 |
GO:0051171 | regulation of nitrogen compound metabolic process | 5.699407e-4 |
GO:0042770 | signal transduction in response to DNA damage | 5.798727e-4 |
GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis | 5.900801e-4 |
GO:0060425 | lung morphogenesis | 6.018809e-4 |
GO:0015701 | bicarbonate transport | 6.068698e-4 |
GO:0030240 | skeletal muscle thin filament assembly | 6.101313e-4 |
GO:0031326 | regulation of cellular biosynthetic process | 6.151081e-4 |
GO:0002429 | immune response-activating cell surface receptor signaling pathway | 6.155693e-4 |
GO:0048638 | regulation of developmental growth | 6.195180e-4 |
GO:0007431 | salivary gland development | 6.229571e-4 |
GO:0060266 | negative regulation of respiratory burst involved in inflammatory response | 6.308709e-4 |
GO:0030241 | skeletal muscle myosin thick filament assembly | 6.390805e-4 |
GO:0032496 | response to lipopolysaccharide | 6.412522e-4 |
GO:0061033 | secretion by lung epithelial cell involved in lung growth | 6.488284e-4 |
GO:0010838 | positive regulation of keratinocyte proliferation | 6.488284e-4 |
GO:0000904 | cell morphogenesis involved in differentiation | 6.618273e-4 |
GO:0006749 | glutathione metabolic process | 6.650138e-4 |
GO:0090286 | cytoskeletal anchoring at nuclear membrane | 6.682220e-4 |
GO:0006554 | lysine catabolic process | 6.682220e-4 |
GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation | 6.857915e-4 |
GO:0016598 | protein arginylation | 6.904415e-4 |
GO:0060206 | estrous cycle phase | 6.936520e-4 |
GO:0032268 | regulation of cellular protein metabolic process | 7.010334e-4 |
GO:0045842 | positive regulation of mitotic metaphase/anaphase transition | 7.019926e-4 |
GO:0019276 | UDP-N-acetylgalactosamine metabolic process | 7.019926e-4 |
GO:0051443 | positive regulation of ubiquitin-protein ligase activity | 7.096994e-4 |
GO:0009889 | regulation of biosynthetic process | 7.120870e-4 |
GO:0071103 | DNA conformation change | 7.273899e-4 |
GO:0000060 | protein import into nucleus, translocation | 7.480842e-4 |
GO:0048850 | hypophysis morphogenesis | 7.547377e-4 |
GO:0048672 | positive regulation of collateral sprouting | 7.583451e-4 |
GO:0006575 | cellular modified amino acid metabolic process | 7.596235e-4 |
GO:0010467 | gene expression | 7.653291e-4 |
GO:0009452 | RNA capping | 7.658563e-4 |
GO:0032774 | RNA biosynthetic process | 7.665752e-4 |
GO:0060523 | prostate epithelial cord elongation | 7.865571e-4 |
GO:0002072 | optic cup morphogenesis involved in camera-type eye development | 7.869053e-4 |
GO:0042891 | antibiotic transport | 7.999410e-4 |
GO:0006323 | DNA packaging | 8.176323e-4 |
GO:0001886 | endothelial cell morphogenesis | 8.330754e-4 |
GO:0044260 | cellular macromolecule metabolic process | 8.333707e-4 |
GO:0010975 | regulation of neuron projection development | 8.338399e-4 |
GO:0001923 | B-1 B cell differentiation | 8.422456e-4 |
GO:2000171 | negative regulation of dendrite development | 8.472037e-4 |
GO:0070172 | positive regulation of tooth mineralization | 8.472037e-4 |
GO:0009063 | cellular amino acid catabolic process | 8.567402e-4 |
GO:0060736 | prostate gland growth | 8.640227e-4 |
GO:0046469 | platelet activating factor metabolic process | 8.727061e-4 |
GO:0044093 | positive regulation of molecular function | 8.925635e-4 |
GO:0010507 | negative regulation of autophagy | 8.965885e-4 |
GO:0030516 | regulation of axon extension | 8.994863e-4 |
GO:0060043 | regulation of cardiac muscle cell proliferation | 9.163831e-4 |
GO:0051592 | response to calcium ion | 9.274685e-4 |
GO:0009435 | NAD biosynthetic process | 9.468872e-4 |
GO:0070212 | protein poly-ADP-ribosylation | 9.477280e-4 |
GO:0060638 | mesenchymal-epithelial cell signaling | 9.678792e-4 |
GO:0071305 | cellular response to vitamin D | 9.708863e-4 |
GO:0032446 | protein modification by small protein conjugation | 9.775678e-4 |
GO:0006351 | transcription, DNA-dependent | 9.901645e-4 |
GO:0045214 | sarcomere organization | 9.948145e-4 |
GO:0018117 | protein adenylylation | 1.013671e-3 |
GO:2000045 | regulation of G1/S transition of mitotic cell cycle | 1.016836e-3 |
GO:0021623 | oculomotor nerve formation | 1.018036e-3 |
GO:0003409 | optic cup structural organization | 1.018036e-3 |
GO:0003404 | optic vesicle morphogenesis | 1.018036e-3 |
GO:0009068 | aspartate family amino acid catabolic process | 1.038039e-3 |
GO:0019362 | pyridine nucleotide metabolic process | 1.044349e-3 |
GO:0003344 | pericardium morphogenesis | 1.058113e-3 |
GO:0055002 | striated muscle cell development | 1.068602e-3 |
GO:0001763 | morphogenesis of a branching structure | 1.070750e-3 |
GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 1.076519e-3 |
GO:0034641 | cellular nitrogen compound metabolic process | 1.091177e-3 |
GO:0060537 | muscle tissue development | 1.105308e-3 |
GO:0022612 | gland morphogenesis | 1.116712e-3 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 1.134764e-3 |
GO:0015705 | iodide transport | 1.136624e-3 |
GO:0048523 | negative regulation of cellular process | 1.157190e-3 |
GO:0032088 | negative regulation of NF-kappaB transcription factor activity | 1.179252e-3 |
GO:0006598 | polyamine catabolic process | 1.185786e-3 |
GO:0009058 | biosynthetic process | 1.200256e-3 |
GO:0070170 | regulation of tooth mineralization | 1.200662e-3 |
GO:0018210 | peptidyl-threonine modification | 1.201747e-3 |
GO:0070093 | negative regulation of glucagon secretion | 1.205642e-3 |
GO:0060900 | embryonic camera-type eye formation | 1.206543e-3 |
GO:0003151 | outflow tract morphogenesis | 1.211061e-3 |
GO:0051329 | interphase of mitotic cell cycle | 1.228193e-3 |
GO:0065007 | biological regulation | 1.255929e-3 |
GO:0019359 | nicotinamide nucleotide biosynthetic process | 1.270570e-3 |
GO:0007346 | regulation of mitotic cell cycle | 1.283538e-3 |
GO:0061039 | ovum-producing ovary development | 1.289296e-3 |
GO:0032963 | collagen metabolic process | 1.292934e-3 |
GO:0061387 | regulation of extent of cell growth | 1.302944e-3 |
GO:0006733 | oxidoreduction coenzyme metabolic process | 1.302944e-3 |
GO:0006072 | glycerol-3-phosphate metabolic process | 1.307122e-3 |
GO:0010976 | positive regulation of neuron projection development | 1.311122e-3 |
GO:0055013 | cardiac muscle cell development | 1.318646e-3 |
GO:0030071 | regulation of mitotic metaphase/anaphase transition | 1.322267e-3 |
GO:0015718 | monocarboxylic acid transport | 1.330612e-3 |
GO:0050794 | regulation of cellular process | 1.341014e-3 |
GO:0050776 | regulation of immune response | 1.366774e-3 |
GO:0055021 | regulation of cardiac muscle tissue growth | 1.386827e-3 |
GO:0051491 | positive regulation of filopodium assembly | 1.391240e-3 |
GO:0010468 | regulation of gene expression | 1.409865e-3 |
GO:0060263 | regulation of respiratory burst | 1.432484e-3 |
GO:0008215 | spermine metabolic process | 1.432728e-3 |
GO:0048747 | muscle fiber development | 1.449761e-3 |
GO:0051050 | positive regulation of transport | 1.469030e-3 |
GO:0001547 | antral ovarian follicle growth | 1.477771e-3 |
GO:0060264 | regulation of respiratory burst involved in inflammatory response | 1.521470e-3 |
GO:0021603 | cranial nerve formation | 1.521470e-3 |
GO:0071281 | cellular response to iron ion | 1.523986e-3 |
GO:0001574 | ganglioside biosynthetic process | 1.524200e-3 |
GO:0048485 | sympathetic nervous system development | 1.526699e-3 |
GO:0031657 | regulation of cyclin-dependent protein kinase activity involved in G1/S | 1.536075e-3 |
GO:0060751 | branch elongation involved in mammary gland duct branching | 1.544324e-3 |
GO:0060412 | ventricular septum morphogenesis | 1.553529e-3 |
GO:0009888 | tissue development | 1.556178e-3 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 1.568245e-3 |
GO:0042981 | regulation of apoptosis | 1.577017e-3 |
GO:0060065 | uterus development | 1.582929e-3 |
GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 1.598129e-3 |
GO:0006370 | mRNA capping | 1.598674e-3 |
GO:0042347 | negative regulation of NF-kappaB import into nucleus | 1.605870e-3 |
GO:0016070 | RNA metabolic process | 1.608839e-3 |
GO:0048699 | generation of neurons | 1.610654e-3 |
GO:0045885 | positive regulation of survival gene product expression | 1.673226e-3 |
GO:0032494 | response to peptidoglycan | 1.673723e-3 |
GO:0009308 | amine metabolic process | 1.726856e-3 |
GO:0070213 | protein auto-ADP-ribosylation | 1.727732e-3 |
GO:0070647 | protein modification by small protein conjugation or removal | 1.731976e-3 |
GO:0072422 | signal transduction involved in DNA damage checkpoint | 1.746954e-3 |
GO:0060688 | regulation of morphogenesis of a branching structure | 1.764411e-3 |
GO:0033598 | mammary gland epithelial cell proliferation | 1.768879e-3 |
GO:0046395 | carboxylic acid catabolic process | 1.796084e-3 |
GO:0003281 | ventricular septum development | 1.820263e-3 |
GO:0060485 | mesenchyme development | 1.827005e-3 |
GO:0070863 | positive regulation of protein exit from endoplasmic reticulum | 1.867091e-3 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.923116e-3 |
GO:0032388 | positive regulation of intracellular transport | 1.926339e-3 |
GO:0006518 | peptide metabolic process | 1.931185e-3 |
GO:0006959 | humoral immune response | 1.960014e-3 |
GO:0055001 | muscle cell development | 1.961014e-3 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.968453e-3 |
GO:0050853 | B cell receptor signaling pathway | 1.976364e-3 |
GO:2000027 | regulation of organ morphogenesis | 1.989558e-3 |
GO:0006491 | N-glycan processing | 2.020098e-3 |
GO:0042178 | xenobiotic catabolic process | 2.027574e-3 |
GO:0002689 | negative regulation of leukocyte chemotaxis | 2.029301e-3 |
GO:0010033 | response to organic substance | 2.038128e-3 |
GO:0033627 | cell adhesion mediated by integrin | 2.094455e-3 |
GO:0046717 | acid secretion | 2.097020e-3 |
GO:0060420 | regulation of heart growth | 2.101180e-3 |
GO:0072404 | signal transduction involved in G1/S transition checkpoint | 2.101503e-3 |
GO:0055024 | regulation of cardiac muscle tissue development | 2.120717e-3 |
GO:0044259 | multicellular organismal macromolecule metabolic process | 2.129008e-3 |
GO:0060042 | retina morphogenesis in camera-type eye | 2.193624e-3 |
GO:0033619 | membrane protein proteolysis | 2.195825e-3 |
GO:0007619 | courtship behavior | 2.202613e-3 |
GO:0019674 | NAD metabolic process | 2.230129e-3 |
GO:0046486 | glycerolipid metabolic process | 2.257572e-3 |
GO:0048468 | cell development | 2.259811e-3 |
GO:0018209 | peptidyl-serine modification | 2.263588e-3 |
GO:0030850 | prostate gland development | 2.263588e-3 |
GO:0090316 | positive regulation of intracellular protein transport | 2.272434e-3 |
GO:0071156 | regulation of cell cycle arrest | 2.288667e-3 |
GO:0048671 | negative regulation of collateral sprouting | 2.326684e-3 |
GO:0072395 | signal transduction involved in cell cycle checkpoint | 2.330225e-3 |
GO:0050771 | negative regulation of axonogenesis | 2.352657e-3 |
GO:0016338 | calcium-independent cell-cell adhesion | 2.357352e-3 |
GO:0043085 | positive regulation of catalytic activity | 2.384783e-3 |
GO:0044267 | cellular protein metabolic process | 2.397733e-3 |
GO:0045926 | negative regulation of growth | 2.404243e-3 |
GO:0006586 | indolalkylamine metabolic process | 2.413214e-3 |
GO:0042990 | regulation of transcription factor import into nucleus | 2.419130e-3 |
GO:0006807 | nitrogen compound metabolic process | 2.474185e-3 |
GO:0070431 | nucleotide-binding oligomerization domain containing 2 signaling pathway | 2.538642e-3 |
GO:0051325 | interphase | 2.571476e-3 |
GO:0003285 | septum secundum development | 2.577500e-3 |
GO:0061350 | planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | 2.599516e-3 |
GO:0061354 | planar cell polarity pathway involved in pericardium morphogenesis | 2.599516e-3 |
GO:0060210 | metestrus | 2.599516e-3 |
GO:0061349 | planar cell polarity pathway involved in cardiac right atrium morphogenesis | 2.599516e-3 |
GO:0061348 | planar cell polarity pathway involved in ventricular septum morphogenesis | 2.599516e-3 |
GO:0061347 | planar cell polarity pathway involved in outflow tract morphogenesis | 2.599516e-3 |
GO:0001510 | RNA methylation | 2.620834e-3 |
GO:0031572 | G2/M transition DNA damage checkpoint | 2.624049e-3 |
GO:0042447 | hormone catabolic process | 2.632640e-3 |
GO:0006582 | melanin metabolic process | 2.643238e-3 |
GO:0016310 | phosphorylation | 2.652192e-3 |
GO:0010039 | response to iron ion | 2.659122e-3 |
GO:0070169 | positive regulation of biomineral tissue development | 2.667866e-3 |
GO:0014060 | regulation of epinephrine secretion | 2.745964e-3 |
GO:0090234 | regulation of kinetochore assembly | 2.780394e-3 |
GO:0090169 | regulation of spindle assembly | 2.780394e-3 |
GO:0006637 | acyl-CoA metabolic process | 2.798607e-3 |
GO:0003179 | heart valve morphogenesis | 2.804813e-3 |
GO:0019222 | regulation of metabolic process | 2.816309e-3 |
GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin | 2.828631e-3 |
GO:0048519 | negative regulation of biological process | 2.829378e-3 |
GO:0030217 | T cell differentiation | 2.856058e-3 |
GO:0002764 | immune response-regulating signaling pathway | 2.938623e-3 |
GO:0000902 | cell morphogenesis | 3.014940e-3 |
GO:0021557 | oculomotor nerve development | 3.018416e-3 |
GO:0048762 | mesenchymal cell differentiation | 3.032153e-3 |
GO:0050673 | epithelial cell proliferation | 3.033140e-3 |
GO:0048103 | somatic stem cell division | 3.052971e-3 |
GO:0051258 | protein polymerization | 3.080722e-3 |
GO:0045884 | regulation of survival gene product expression | 3.095702e-3 |
GO:0043067 | regulation of programmed cell death | 3.097476e-3 |
GO:0071219 | cellular response to molecule of bacterial origin | 3.133108e-3 |
GO:0010921 | regulation of phosphatase activity | 3.146540e-3 |
GO:0031340 | positive regulation of vesicle fusion | 3.147160e-3 |
GO:0072201 | negative regulation of mesenchymal cell proliferation | 3.149617e-3 |
GO:0048853 | forebrain morphogenesis | 3.169533e-3 |
GO:0035272 | exocrine system development | 3.240473e-3 |
GO:0006520 | cellular amino acid metabolic process | 3.284768e-3 |
GO:0010922 | positive regulation of phosphatase activity | 3.297563e-3 |
GO:0006509 | membrane protein ectodomain proteolysis | 3.309380e-3 |
GO:0042127 | regulation of cell proliferation | 3.309784e-3 |
GO:0009066 | aspartate family amino acid metabolic process | 3.337935e-3 |
GO:0010556 | regulation of macromolecule biosynthetic process | 3.338698e-3 |
GO:0003289 | atrial septum primum morphogenesis | 3.367520e-3 |
GO:0046329 | negative regulation of JNK cascade | 3.371008e-3 |
GO:0070633 | transepithelial transport | 3.377694e-3 |
GO:0045087 | innate immune response | 3.382750e-3 |
GO:0021506 | anterior neuropore closure | 3.391827e-3 |
GO:0006820 | anion transport | 3.449908e-3 |
GO:0046660 | female sex differentiation | 3.485870e-3 |
GO:0050789 | regulation of biological process | 3.488636e-3 |
GO:0051246 | regulation of protein metabolic process | 3.509123e-3 |
GO:0030888 | regulation of B cell proliferation | 3.546551e-3 |
GO:0050773 | regulation of dendrite development | 3.552408e-3 |
GO:0010716 | negative regulation of extracellular matrix disassembly | 3.568974e-3 |
GO:0071477 | cellular hypotonic salinity response | 3.578559e-3 |
GO:0060676 | ureteric bud formation | 3.603684e-3 |
GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator | 3.703395e-3 |
GO:0045664 | regulation of neuron differentiation | 3.706302e-3 |
GO:0009410 | response to xenobiotic stimulus | 3.748578e-3 |
GO:0042308 | negative regulation of protein import into nucleus | 3.749992e-3 |
GO:0060067 | cervix development | 3.752657e-3 |
GO:0061138 | morphogenesis of a branching epithelium | 3.788672e-3 |
GO:0065009 | regulation of molecular function | 3.791017e-3 |
GO:0034080 | CenH3-containing nucleosome assembly at centromere | 3.843224e-3 |
GO:0071222 | cellular response to lipopolysaccharide | 3.920399e-3 |
GO:0045086 | positive regulation of interleukin-2 biosynthetic process | 3.960541e-3 |
GO:0010820 | positive regulation of T cell chemotaxis | 3.981267e-3 |
GO:0002360 | T cell lineage commitment | 3.981267e-3 |
GO:0010927 | cellular component assembly involved in morphogenesis | 3.985367e-3 |
GO:0009653 | anatomical structure morphogenesis | 3.988934e-3 |
GO:0090370 | negative regulation of cholesterol efflux | 3.990455e-3 |
GO:0030501 | positive regulation of bone mineralization | 4.006290e-3 |
GO:0003170 | heart valve development | 4.011999e-3 |
GO:0006732 | coenzyme metabolic process | 4.100136e-3 |
GO:0032270 | positive regulation of cellular protein metabolic process | 4.184205e-3 |
GO:0009719 | response to endogenous stimulus | 4.226174e-3 |
GO:0042404 | thyroid hormone catabolic process | 4.230883e-3 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 4.245988e-3 |
GO:0008361 | regulation of cell size | 4.254578e-3 |
GO:0002757 | immune response-activating signal transduction | 4.255500e-3 |
GO:0044243 | multicellular organismal catabolic process | 4.265117e-3 |
GO:0042994 | cytoplasmic sequestering of transcription factor | 4.357504e-3 |
GO:0006952 | defense response | 4.373262e-3 |
GO:0031345 | negative regulation of cell projection organization | 4.407883e-3 |
GO:0032502 | developmental process | 4.412310e-3 |
GO:0000186 | activation of MAPKK activity | 4.420582e-3 |
GO:0043525 | positive regulation of neuron apoptosis | 4.422354e-3 |
GO:0016567 | protein ubiquitination | 4.441935e-3 |
GO:0019432 | triglyceride biosynthetic process | 4.454159e-3 |
GO:0071877 | regulation of adrenergic receptor signaling pathway | 4.513905e-3 |
GO:0016055 | Wnt receptor signaling pathway | 4.573355e-3 |
GO:0033157 | regulation of intracellular protein transport | 4.593577e-3 |
GO:0008585 | female gonad development | 4.663165e-3 |
GO:0044282 | small molecule catabolic process | 4.754462e-3 |
GO:0032212 | positive regulation of telomere maintenance via telomerase | 4.773737e-3 |
GO:0048596 | embryonic camera-type eye morphogenesis | 4.793732e-3 |
GO:0031571 | mitotic cell cycle G1/S transition DNA damage checkpoint | 4.798568e-3 |
GO:0006688 | glycosphingolipid biosynthetic process | 4.803051e-3 |
GO:0060209 | estrus | 4.832071e-3 |
GO:0032873 | negative regulation of stress-activated MAPK cascade | 4.847642e-3 |
GO:0030307 | positive regulation of cell growth | 4.852728e-3 |
GO:0007413 | axonal fasciculation | 4.864582e-3 |
GO:0048646 | anatomical structure formation involved in morphogenesis | 4.868828e-3 |
GO:0006913 | nucleocytoplasmic transport | 4.894461e-3 |
GO:0071466 | cellular response to xenobiotic stimulus | 4.900170e-3 |
GO:0006081 | cellular aldehyde metabolic process | 4.919907e-3 |
GO:0071495 | cellular response to endogenous stimulus | 4.924478e-3 |
GO:0030514 | negative regulation of BMP signaling pathway | 4.925691e-3 |
GO:0002064 | epithelial cell development | 4.979193e-3 |
GO:0019363 | pyridine nucleotide biosynthetic process | 4.988826e-3 |
GO:0051452 | intracellular pH reduction | 5.043698e-3 |
GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway | 5.047654e-3 |
GO:0009266 | response to temperature stimulus | 5.063858e-3 |
GO:0002313 | mature B cell differentiation involved in immune response | 5.104120e-3 |
GO:0035625 | epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway | 5.117579e-3 |
GO:0051247 | positive regulation of protein metabolic process | 5.143977e-3 |
GO:0018107 | peptidyl-threonine phosphorylation | 5.150090e-3 |
GO:0071216 | cellular response to biotic stimulus | 5.170169e-3 |
GO:0022008 | neurogenesis | 5.183734e-3 |
GO:0043648 | dicarboxylic acid metabolic process | 5.246239e-3 |
GO:0048518 | positive regulation of biological process | 5.320968e-3 |
GO:0014866 | skeletal myofibril assembly | 5.326909e-3 |
GO:0007254 | JNK cascade | 5.363071e-3 |
GO:0048511 | rhythmic process | 5.375090e-3 |
GO:0019370 | leukotriene biosynthetic process | 5.405406e-3 |
GO:0030201 | heparan sulfate proteoglycan metabolic process | 5.410196e-3 |
GO:0046823 | negative regulation of nucleocytoplasmic transport | 5.569872e-3 |
GO:0060021 | palate development | 5.587136e-3 |
GO:0051549 | positive regulation of keratinocyte migration | 5.607718e-3 |
GO:0060743 | epithelial cell maturation involved in prostate gland development | 5.607718e-3 |
GO:0006570 | tyrosine metabolic process | 5.607718e-3 |
GO:0003407 | neural retina development | 5.636602e-3 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0090074 | negative regulation of protein homodimerization activity | 1.704975e-10 |
GO:0051257 | spindle midzone assembly involved in meiosis | 3.570405e-10 |
GO:0000019 | regulation of mitotic recombination | 5.262541e-10 |
GO:0007016 | cytoskeletal anchoring at plasma membrane | 3.370540e-9 |
GO:0043060 | meiotic metaphase I plate congression | 3.444497e-9 |
GO:0000239 | pachytene | 4.392054e-9 |
GO:0045950 | negative regulation of mitotic recombination | 7.112167e-9 |
GO:0051255 | spindle midzone assembly | 9.936509e-9 |
GO:0007060 | male meiosis chromosome segregation | 1.365751e-8 |
GO:0034329 | cell junction assembly | 8.530346e-8 |
GO:0022402 | cell cycle process | 5.303221e-7 |
GO:0000712 | resolution of meiotic recombination intermediates | 6.016771e-7 |
GO:0051307 | meiotic chromosome separation | 8.823813e-7 |
GO:0006303 | double-strand break repair via nonhomologous end joining | 9.978622e-7 |
GO:0034330 | cell junction organization | 3.114775e-6 |
GO:0006302 | double-strand break repair | 3.393820e-6 |
GO:0050930 | induction of positive chemotaxis | 4.171075e-6 |
GO:0000726 | non-recombinational repair | 5.022378e-6 |
GO:0043496 | regulation of protein homodimerization activity | 6.319214e-6 |
GO:0045143 | homologous chromosome segregation | 6.805966e-6 |
GO:0007044 | cell-substrate junction assembly | 7.642713e-6 |
GO:0033554 | cellular response to stress | 1.104719e-5 |
GO:0008360 | regulation of cell shape | 1.129326e-5 |
GO:0022403 | cell cycle phase | 1.174317e-5 |
GO:0030866 | cortical actin cytoskeleton organization | 1.237346e-5 |
GO:0071842 | cellular component organization at cellular level | 1.548239e-5 |
GO:0042443 | phenylethylamine metabolic process | 1.672658e-5 |
GO:0030865 | cortical cytoskeleton organization | 1.815131e-5 |
GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening | 2.134025e-5 |
GO:0002312 | B cell activation involved in immune response | 2.180642e-5 |
GO:0006665 | sphingolipid metabolic process | 2.757788e-5 |
GO:0030335 | positive regulation of cell migration | 2.906232e-5 |
GO:0007184 | SMAD protein import into nucleus | 3.114809e-5 |
GO:0006643 | membrane lipid metabolic process | 3.621034e-5 |
GO:0016446 | somatic hypermutation of immunoglobulin genes | 3.982032e-5 |
GO:0040017 | positive regulation of locomotion | 3.983896e-5 |
GO:0071841 | cellular component organization or biogenesis at cellular level | 4.228030e-5 |
GO:0045190 | isotype switching | 4.579457e-5 |
GO:0016043 | cellular component organization | 5.769422e-5 |
GO:2000147 | positive regulation of cell motility | 5.786928e-5 |
GO:0046007 | negative regulation of activated T cell proliferation | 5.831699e-5 |
GO:0006259 | DNA metabolic process | 5.956907e-5 |
GO:2000351 | regulation of endothelial cell apoptosis | 6.416052e-5 |
GO:0050927 | positive regulation of positive chemotaxis | 6.457032e-5 |
GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway | 6.976933e-5 |
GO:0045653 | negative regulation of megakaryocyte differentiation | 7.563904e-5 |
GO:0050926 | regulation of positive chemotaxis | 8.288026e-5 |
GO:0007128 | meiotic prophase I | 9.891540e-5 |
GO:0034394 | protein localization at cell surface | 1.061279e-4 |
GO:0071840 | cellular component organization or biogenesis | 1.200399e-4 |
GO:0051310 | metaphase plate congression | 1.329953e-4 |
GO:0006393 | termination of mitochondrial transcription | 1.427080e-4 |
GO:0051272 | positive regulation of cellular component movement | 1.489184e-4 |
GO:0042147 | retrograde transport, endosome to Golgi | 1.744182e-4 |
GO:0019550 | glutamate catabolic process to aspartate | 1.782973e-4 |
GO:0045659 | negative regulation of neutrophil differentiation | 1.782973e-4 |
GO:0019551 | glutamate catabolic process to 2-oxoglutarate | 1.782973e-4 |
GO:0006533 | aspartate catabolic process | 1.782973e-4 |
GO:0006532 | aspartate biosynthetic process | 1.782973e-4 |
GO:0000278 | mitotic cell cycle | 1.818927e-4 |
GO:0045132 | meiotic chromosome segregation | 1.832455e-4 |
GO:0043129 | surfactant homeostasis | 2.105078e-4 |
GO:0007131 | reciprocal meiotic recombination | 2.142400e-4 |
GO:0051303 | establishment of chromosome localization | 2.223661e-4 |
GO:0043558 | regulation of translational initiation in response to stress | 2.461303e-4 |
GO:0045104 | intermediate filament cytoskeleton organization | 2.583979e-4 |
GO:0006298 | mismatch repair | 2.663012e-4 |
GO:0006531 | aspartate metabolic process | 2.862055e-4 |
GO:0006974 | response to DNA damage stimulus | 3.149256e-4 |
GO:0045103 | intermediate filament-based process | 3.261752e-4 |
GO:0000279 | M phase | 3.296273e-4 |
GO:0006106 | fumarate metabolic process | 3.307528e-4 |
GO:0006048 | UDP-N-acetylglucosamine biosynthetic process | 3.456213e-4 |
GO:0008090 | retrograde axon cargo transport | 3.558203e-4 |
GO:0051928 | positive regulation of calcium ion transport | 3.668387e-4 |
GO:0006281 | DNA repair | 3.800762e-4 |
GO:0048520 | positive regulation of behavior | 3.974346e-4 |
GO:0010837 | regulation of keratinocyte proliferation | 4.404805e-4 |
GO:0007158 | neuron cell-cell adhesion | 4.404805e-4 |
GO:0007049 | cell cycle | 4.799020e-4 |
GO:0006672 | ceramide metabolic process | 5.084911e-4 |
GO:0009068 | aspartate family amino acid catabolic process | 5.579010e-4 |
GO:0006042 | glucosamine biosynthetic process | 5.617210e-4 |
GO:0007010 | cytoskeleton organization | 5.757479e-4 |
GO:0019227 | neuronal action potential propagation | 6.562216e-4 |
GO:0090272 | negative regulation of fibroblast growth factor production | 6.959130e-4 |
GO:0046349 | amino sugar biosynthetic process | 6.959130e-4 |
GO:0045656 | negative regulation of monocyte differentiation | 7.077534e-4 |
GO:0045409 | negative regulation of interleukin-6 biosynthetic process | 7.099792e-4 |
GO:0002381 | immunoglobulin production involved in immunoglobulin mediated immune response | 7.334051e-4 |
GO:0061033 | secretion by lung epithelial cell involved in lung growth | 7.915516e-4 |
GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 8.025909e-4 |
GO:0000018 | regulation of DNA recombination | 8.419711e-4 |
GO:0014908 | myotube differentiation involved in skeletal muscle regeneration | 8.426852e-4 |
GO:0007518 | myoblast cell fate determination | 8.426852e-4 |
GO:0043297 | apical junction assembly | 8.989637e-4 |
GO:0002366 | leukocyte activation involved in immune response | 9.245193e-4 |
GO:0019322 | pentose biosynthetic process | 9.797307e-4 |
GO:0050795 | regulation of behavior | 9.991944e-4 |
GO:0045652 | regulation of megakaryocyte differentiation | 1.009690e-3 |
GO:0040011 | locomotion | 1.011896e-3 |
GO:0032514 | positive regulation of protein phosphatase type 2B activity | 1.021664e-3 |
GO:0009066 | aspartate family amino acid metabolic process | 1.089639e-3 |
GO:0097115 | neurexin clustering | 1.104448e-3 |
GO:2000352 | negative regulation of endothelial cell apoptosis | 1.108678e-3 |
GO:0030514 | negative regulation of BMP signaling pathway | 1.138479e-3 |
GO:0046677 | response to antibiotic | 1.140853e-3 |
GO:0016447 | somatic recombination of immunoglobulin gene segments | 1.201495e-3 |
GO:0046519 | sphingoid metabolic process | 1.307965e-3 |
GO:0006798 | polyphosphate catabolic process | 1.393324e-3 |
GO:0060271 | cilium morphogenesis | 1.481831e-3 |
GO:0016079 | synaptic vesicle exocytosis | 1.626259e-3 |
GO:0061101 | neuroendocrine cell differentiation | 1.667653e-3 |
GO:0002562 | somatic diversification of immune receptors via germline recombination within a single locus | 1.698789e-3 |
GO:0006667 | sphinganine metabolic process | 1.729900e-3 |
GO:0016445 | somatic diversification of immunoglobulins | 1.758217e-3 |
GO:0050921 | positive regulation of chemotaxis | 1.763397e-3 |
GO:0006687 | glycosphingolipid metabolic process | 1.821207e-3 |
GO:0043555 | regulation of translation in response to stress | 1.885040e-3 |
GO:0006538 | glutamate catabolic process | 1.885040e-3 |
GO:0032915 | positive regulation of transforming growth factor beta2 production | 1.928373e-3 |
GO:0030510 | regulation of BMP signaling pathway | 1.987889e-3 |
GO:0035335 | peptidyl-tyrosine dephosphorylation | 2.038292e-3 |
GO:0090101 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 2.122445e-3 |
GO:0050672 | negative regulation of lymphocyte proliferation | 2.197048e-3 |
GO:0002200 | somatic diversification of immune receptors | 2.197048e-3 |
GO:0061370 | testosterone biosynthetic process | 2.213101e-3 |
GO:0043065 | positive regulation of apoptosis | 2.328530e-3 |
GO:0090092 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 2.384782e-3 |
GO:0045910 | negative regulation of DNA recombination | 2.390037e-3 |
GO:0050920 | regulation of chemotaxis | 2.396106e-3 |
GO:0035234 | germ cell programmed cell death | 2.407789e-3 |
GO:0007589 | body fluid secretion | 2.417157e-3 |
GO:0070664 | negative regulation of leukocyte proliferation | 2.427835e-3 |
GO:0002252 | immune effector process | 2.500507e-3 |
GO:0009051 | pentose-phosphate shunt, oxidative branch | 2.522566e-3 |
GO:0006935 | chemotaxis | 2.562397e-3 |
GO:0006664 | glycolipid metabolic process | 2.618594e-3 |
GO:0097091 | synaptic vesicle clustering | 2.688319e-3 |
GO:0042330 | taxis | 2.691954e-3 |
GO:0034605 | cellular response to heat | 2.715366e-3 |
GO:0030888 | regulation of B cell proliferation | 2.762093e-3 |
GO:0030049 | muscle filament sliding | 2.828584e-3 |
GO:0042035 | regulation of cytokine biosynthetic process | 2.871720e-3 |
GO:0043538 | regulation of actin phosphorylation | 2.879772e-3 |
GO:0043068 | positive regulation of programmed cell death | 2.928549e-3 |
GO:0030011 | maintenance of cell polarity | 2.930127e-3 |
GO:0050871 | positive regulation of B cell activation | 3.035687e-3 |
GO:0097113 | alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor clustering | 3.090141e-3 |
GO:0045086 | positive regulation of interleukin-2 biosynthetic process | 3.099717e-3 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 3.143549e-3 |
GO:0030889 | negative regulation of B cell proliferation | 3.185119e-3 |
GO:0016080 | synaptic vesicle targeting | 3.185594e-3 |
GO:0045590 | negative regulation of regulatory T cell differentiation | 3.218445e-3 |
GO:0045655 | regulation of monocyte differentiation | 3.256357e-3 |
GO:0051640 | organelle localization | 3.274521e-3 |
GO:0032274 | gonadotropin secretion | 3.297161e-3 |
GO:0006996 | organelle organization | 3.298194e-3 |
GO:0006401 | RNA catabolic process | 3.387189e-3 |
GO:0002281 | macrophage activation involved in immune response | 3.428907e-3 |
GO:0042384 | cilium assembly | 3.433312e-3 |
GO:0022607 | cellular component assembly | 3.461094e-3 |
GO:0022603 | regulation of anatomical structure morphogenesis | 3.539529e-3 |
GO:0097105 | presynaptic membrane assembly | 3.601265e-3 |
GO:0052033 | pathogen-associated molecular pattern dependent induction by symbiont of host innate immunity | 3.606139e-3 |
GO:0051549 | positive regulation of keratinocyte migration | 3.736182e-3 |
GO:0000082 | G1/S transition of mitotic cell cycle | 3.806297e-3 |
GO:0032909 | regulation of transforming growth factor beta2 production | 3.899890e-3 |
GO:0010738 | regulation of protein kinase A signaling cascade | 4.055892e-3 |
GO:0008630 | DNA damage response, signal transduction resulting in induction of apoptosis | 4.059903e-3 |
GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 4.149291e-3 |
GO:0072578 | neurotransmitter-gated ion channel clustering | 4.216458e-3 |
GO:0097120 | receptor localization to synapse | 4.216458e-3 |
GO:0051966 | regulation of synaptic transmission, glutamatergic | 4.320291e-3 |
GO:0008088 | axon cargo transport | 4.391588e-3 |
GO:0097090 | presynaptic membrane organization | 4.551600e-3 |
GO:0010942 | positive regulation of cell death | 4.588053e-3 |
GO:0022038 | corpus callosum development | 4.604706e-3 |
GO:0060986 | endocrine hormone secretion | 4.641992e-3 |
GO:0051968 | positive regulation of synaptic transmission, glutamatergic | 4.641992e-3 |
GO:0045408 | regulation of interleukin-6 biosynthetic process | 4.726333e-3 |
GO:0002285 | lymphocyte activation involved in immune response | 4.783252e-3 |
GO:0045321 | leukocyte activation | 4.807314e-3 |
GO:0051135 | positive regulation of NK T cell activation | 4.854432e-3 |
GO:0018009 | N-terminal peptidyl-L-cysteine N-palmitoylation | 4.858944e-3 |
GO:0002443 | leukocyte mediated immunity | 4.889779e-3 |
GO:0002320 | lymphoid progenitor cell differentiation | 4.903202e-3 |
GO:0090270 | regulation of fibroblast growth factor production | 4.935198e-3 |
GO:0002282 | microglial cell activation involved in immune response | 4.935198e-3 |
GO:0003151 | outflow tract morphogenesis | 5.026472e-3 |
GO:0006310 | DNA recombination | 5.026790e-3 |
GO:0060437 | lung growth | 5.165411e-3 |
GO:0010838 | positive regulation of keratinocyte proliferation | 5.165411e-3 |
GO:0007140 | male meiosis | 5.201886e-3 |
GO:0042127 | regulation of cell proliferation | 5.220977e-3 |
GO:0035904 | aorta development | 5.368313e-3 |
GO:0007522 | visceral muscle development | 5.529910e-3 |
GO:0042770 | signal transduction in response to DNA damage | 5.569212e-3 |
GO:0032091 | negative regulation of protein binding | 5.654691e-3 |
GO:0007050 | cell cycle arrest | 5.673981e-3 |
GO:0060999 | positive regulation of dendritic spine development | 5.674786e-3 |
GO:0006402 | mRNA catabolic process | 5.800026e-3 |
GO:0045658 | regulation of neutrophil differentiation | 5.826762e-3 |
GO:0051290 | protein heterotetramerization | 5.879986e-3 |
GO:0032512 | regulation of protein phosphatase type 2B activity | 5.964709e-3 |
GO:0007043 | cell-cell junction assembly | 6.034456e-3 |
GO:0001574 | ganglioside biosynthetic process | 6.090540e-3 |
GO:0030157 | pancreatic juice secretion | 6.177603e-3 |
GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity | 6.306527e-3 |
GO:0006383 | transcription from RNA polymerase III promoter | 6.523890e-3 |
GO:0007126 | meiosis | 6.550476e-3 |
GO:0002440 | production of molecular mediator of immune response | 6.634353e-3 |
GO:0051260 | protein homooligomerization | 6.740667e-3 |
GO:0002377 | immunoglobulin production | 6.840473e-3 |
GO:0090304 | nucleic acid metabolic process | 6.890951e-3 |
GO:0097119 | postsynaptic density protein 95 clustering | 7.226364e-3 |
GO:0097104 | postsynaptic membrane assembly | 7.226364e-3 |
GO:0043270 | positive regulation of ion transport | 7.235996e-3 |
GO:0050806 | positive regulation of synaptic transmission | 7.267132e-3 |
GO:0034154 | toll-like receptor 7 signaling pathway | 7.306623e-3 |
GO:0035909 | aorta morphogenesis | 7.417916e-3 |
GO:0051656 | establishment of organelle localization | 7.602790e-3 |
GO:0032103 | positive regulation of response to external stimulus | 7.614556e-3 |
GO:0050793 | regulation of developmental process | 7.643600e-3 |
GO:0031122 | cytoplasmic microtubule organization | 7.720907e-3 |
GO:0006566 | threonine metabolic process | 7.733122e-3 |
GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly | 7.733122e-3 |
GO:0071634 | regulation of transforming growth factor beta production | 7.981123e-3 |
GO:0060346 | bone trabecula formation | 8.052453e-3 |
GO:0051321 | meiotic cell cycle | 8.100915e-3 |
GO:0006583 | melanin biosynthetic process from tyrosine | 8.383895e-3 |
GO:0034337 | RNA folding | 8.412719e-3 |
GO:0051100 | negative regulation of binding | 8.440572e-3 |
GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway | 8.505096e-3 |
GO:0048692 | negative regulation of axon extension involved in regeneration | 8.698824e-3 |
GO:0051971 | positive regulation of transmission of nerve impulse | 8.802830e-3 |
GO:0071844 | cellular component assembly at cellular level | 8.855862e-3 |
GO:0006139 | nucleobase-containing compound metabolic process | 8.878355e-3 |
GO:0045668 | negative regulation of osteoblast differentiation | 8.910431e-3 |
GO:0007254 | JNK cascade | 8.944394e-3 |
GO:0048304 | positive regulation of isotype switching to IgG isotypes | 9.063201e-3 |
GO:0052556 | positive regulation by symbiont of host immune response | 9.065875e-3 |
GO:0052509 | positive regulation by symbiont of host defense response | 9.065875e-3 |
GO:0044260 | cellular macromolecule metabolic process | 9.179521e-3 |
GO:0022604 | regulation of cell morphogenesis | 9.304312e-3 |
GO:0060037 | pharyngeal system development | 9.466040e-3 |
GO:0000724 | double-strand break repair via homologous recombination | 9.466040e-3 |
GO:0042420 | dopamine catabolic process | 9.779358e-3 |
GO:0000087 | M phase of mitotic cell cycle | 9.867068e-3 |
GO:0002520 | immune system development | 9.903467e-3 |
GO:0071044 | histone mRNA catabolic process | 9.979593e-3 |
GO:0045066 | regulatory T cell differentiation | 9.979593e-3 |
GO:0045356 | positive regulation of interferon-alpha biosynthetic process | 1.019946e-2 |
GO:0046373 | L-arabinose metabolic process | 1.019946e-2 |
GO:0001774 | microglial cell activation | 1.047738e-2 |
GO:0019321 | pentose metabolic process | 1.050398e-2 |
GO:0016338 | calcium-independent cell-cell adhesion | 1.050398e-2 |
GO:0044029 | hypomethylation of CpG island | 1.056603e-2 |
GO:0044085 | cellular component biogenesis | 1.070605e-2 |
GO:0045076 | regulation of interleukin-2 biosynthetic process | 1.079882e-2 |
GO:0034637 | cellular carbohydrate biosynthetic process | 1.088115e-2 |
GO:0046165 | alcohol biosynthetic process | 1.088115e-2 |
GO:0000132 | establishment of mitotic spindle orientation | 1.088454e-2 |
GO:0046903 | secretion | 1.101548e-2 |
GO:0032663 | regulation of interleukin-2 production | 1.102076e-2 |
GO:0000725 | recombinational repair | 1.105286e-2 |
GO:2000463 | positive regulation of excitatory postsynaptic membrane potential | 1.121147e-2 |
GO:0050869 | negative regulation of B cell activation | 1.143819e-2 |
GO:0031646 | positive regulation of neurological system process | 1.149538e-2 |
GO:0045078 | positive regulation of interferon-gamma biosynthetic process | 1.152042e-2 |
GO:0051651 | maintenance of location in cell | 1.156894e-2 |
GO:0071544 | diphosphoinositol polyphosphate catabolic process | 1.180575e-2 |
GO:0010508 | positive regulation of autophagy | 1.206602e-2 |
GO:0050670 | regulation of lymphocyte proliferation | 1.233069e-2 |
GO:0060411 | cardiac septum morphogenesis | 1.246699e-2 |
GO:0040001 | establishment of mitotic spindle localization | 1.258864e-2 |
GO:0055067 | monovalent inorganic cation homeostasis | 1.263323e-2 |
GO:0051225 | spindle assembly | 1.282404e-2 |
GO:0016339 | calcium-dependent cell-cell adhesion | 1.282404e-2 |
GO:2000026 | regulation of multicellular organismal development | 1.283567e-2 |
GO:0030334 | regulation of cell migration | 1.289820e-2 |
GO:0072657 | protein localization in membrane | 1.290551e-2 |
GO:0050864 | regulation of B cell activation | 1.293589e-2 |
GO:0048752 | semicircular canal morphogenesis | 1.295065e-2 |
GO:0016576 | histone dephosphorylation | 1.295337e-2 |
GO:0070925 | organelle assembly | 1.305599e-2 |
GO:0032944 | regulation of mononuclear cell proliferation | 1.312974e-2 |
GO:0032507 | maintenance of protein location in cell | 1.314931e-2 |
GO:0043113 | receptor clustering | 1.318024e-2 |
GO:0045779 | negative regulation of bone resorption | 1.320620e-2 |
GO:0042116 | macrophage activation | 1.331988e-2 |
GO:0035418 | protein localization to synapse | 1.331988e-2 |
GO:0031581 | hemidesmosome assembly | 1.352114e-2 |
GO:0043982 | histone H4-K8 acetylation | 1.382795e-2 |
GO:0052572 | response to host immune response | 1.382795e-2 |
GO:0043981 | histone H4-K5 acetylation | 1.382795e-2 |
GO:0030148 | sphingolipid biosynthetic process | 1.384010e-2 |
GO:0045648 | positive regulation of erythrocyte differentiation | 1.399714e-2 |
GO:0070663 | regulation of leukocyte proliferation | 1.435782e-2 |
GO:0005977 | glycogen metabolic process | 1.444246e-2 |
GO:0006955 | immune response | 1.446037e-2 |
GO:0042424 | catecholamine catabolic process | 1.473530e-2 |
GO:2000279 | negative regulation of DNA biosynthetic process | 1.494211e-2 |
GO:0071407 | cellular response to organic cyclic compound | 1.530698e-2 |
GO:0090177 | establishment of planar polarity involved in neural tube closure | 1.532439e-2 |
GO:0018149 | peptide cross-linking | 1.536606e-2 |
GO:0032836 | glomerular basement membrane development | 1.567557e-2 |
GO:0072513 | positive regulation of secondary heart field cardioblast proliferation | 1.567557e-2 |
GO:0006047 | UDP-N-acetylglucosamine metabolic process | 1.567557e-2 |
GO:0033275 | actin-myosin filament sliding | 1.583230e-2 |
GO:0046467 | membrane lipid biosynthetic process | 1.586409e-2 |
GO:0009065 | glutamine family amino acid catabolic process | 1.594290e-2 |
GO:0007017 | microtubule-based process | 1.619416e-2 |
GO:0007007 | inner mitochondrial membrane organization | 1.645962e-2 |
GO:0051325 | interphase | 1.648608e-2 |
GO:0034505 | tooth mineralization | 1.654194e-2 |
GO:2000145 | regulation of cell motility | 1.677684e-2 |
GO:0045185 | maintenance of protein location | 1.679835e-2 |
GO:0031124 | mRNA 3'-end processing | 1.681234e-2 |
GO:0042100 | B cell proliferation | 1.697299e-2 |
GO:0046836 | glycolipid transport | 1.723143e-2 |
GO:0006601 | creatine biosynthetic process | 1.723143e-2 |
GO:0051301 | cell division | 1.741527e-2 |
GO:0090288 | negative regulation of cellular response to growth factor stimulus | 1.742436e-2 |
GO:0051235 | maintenance of location | 1.762297e-2 |
GO:2000353 | positive regulation of endothelial cell apoptosis | 1.765526e-2 |
GO:0016197 | endosome transport | 1.776964e-2 |
GO:0045786 | negative regulation of cell cycle | 1.779834e-2 |
GO:0002449 | lymphocyte mediated immunity | 1.796135e-2 |
GO:0034641 | cellular nitrogen compound metabolic process | 1.796968e-2 |
GO:0002446 | neutrophil mediated immunity | 1.807614e-2 |
GO:0003279 | cardiac septum development | 1.817001e-2 |
GO:0048066 | developmental pigmentation | 1.864354e-2 |
GO:0042359 | vitamin D metabolic process | 1.869486e-2 |
GO:0044003 | modification by symbiont of host morphology or physiology | 1.893734e-2 |
GO:0000226 | microtubule cytoskeleton organization | 1.896727e-2 |
GO:0042119 | neutrophil activation | 1.917421e-2 |
GO:0035641 | locomotory exploration behavior | 1.917421e-2 |
GO:0031098 | stress-activated protein kinase signaling cascade | 1.920119e-2 |
GO:0016064 | immunoglobulin mediated immune response | 1.920119e-2 |
GO:0090287 | regulation of cellular response to growth factor stimulus | 1.925350e-2 |
GO:0033077 | T cell differentiation in thymus | 1.927663e-2 |
GO:0051270 | regulation of cellular component movement | 1.946805e-2 |
GO:0002689 | negative regulation of leukocyte chemotaxis | 1.976771e-2 |
GO:0008354 | germ cell migration | 1.977045e-2 |
GO:0045838 | positive regulation of membrane potential | 1.977049e-2 |
GO:0072176 | nephric duct development | 1.979400e-2 |
GO:0001922 | B-1 B cell homeostasis | 1.979400e-2 |
GO:0019724 | B cell mediated immunity | 2.049695e-2 |
GO:0051053 | negative regulation of DNA metabolic process | 2.057845e-2 |
GO:0044030 | regulation of DNA methylation | 2.076622e-2 |
GO:0006688 | glycosphingolipid biosynthetic process | 2.076622e-2 |
GO:0055078 | sodium ion homeostasis | 2.087385e-2 |
GO:0090224 | regulation of spindle organization | 2.087385e-2 |
GO:0006498 | N-terminal protein lipidation | 2.132797e-2 |
GO:0045216 | cell-cell junction organization | 2.136731e-2 |
GO:0045072 | regulation of interferon-gamma biosynthetic process | 2.147868e-2 |
GO:0007257 | activation of JUN kinase activity | 2.151718e-2 |
GO:0048302 | regulation of isotype switching to IgG isotypes | 2.179536e-2 |
GO:0016051 | carbohydrate biosynthetic process | 2.179870e-2 |
GO:0060134 | prepulse inhibition | 2.224587e-2 |
GO:0001941 | postsynaptic membrane organization | 2.232260e-2 |
GO:0070252 | actin-mediated cell contraction | 2.237488e-2 |
GO:0048739 | cardiac muscle fiber development | 2.237488e-2 |
GO:0046164 | alcohol catabolic process | 2.284335e-2 |
GO:0030224 | monocyte differentiation | 2.285836e-2 |
GO:0002376 | immune system process | 2.295960e-2 |
GO:0046514 | ceramide catabolic process | 2.310502e-2 |
GO:0009448 | gamma-aminobutyric acid metabolic process | 2.318608e-2 |
GO:0051179 | localization | 2.334531e-2 |
GO:0035590 | purinergic nucleotide receptor signaling pathway | 2.335870e-2 |
GO:0006903 | vesicle targeting | 2.340268e-2 |
GO:0008593 | regulation of Notch signaling pathway | 2.349745e-2 |
GO:0060490 | lateral sprouting involved in lung morphogenesis | 2.351245e-2 |
GO:0060489 | planar dichotomous subdivision of terminal units involved in lung branching morphogenesis | 2.351245e-2 |
GO:0060488 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis | 2.351245e-2 |
GO:0035880 | embryonic nail plate morphogenesis | 2.351245e-2 |
GO:0048105 | establishment of body hair planar orientation | 2.351245e-2 |
GO:0071236 | cellular response to antibiotic | 2.354232e-2 |
GO:0070126 | mitochondrial translational termination | 2.375790e-2 |
GO:0060676 | ureteric bud formation | 2.394547e-2 |
GO:2000677 | regulation of transcription regulatory region DNA binding | 2.395563e-2 |
GO:0048743 | positive regulation of skeletal muscle fiber development | 2.420842e-2 |
GO:0071675 | regulation of mononuclear cell migration | 2.420842e-2 |
GO:0003416 | endochondral bone growth | 2.420842e-2 |
GO:0001573 | ganglioside metabolic process | 2.451725e-2 |
GO:0001782 | B cell homeostasis | 2.467796e-2 |
GO:0046851 | negative regulation of bone remodeling | 2.480420e-2 |
GO:0051293 | establishment of spindle localization | 2.508758e-2 |
GO:0060872 | semicircular canal development | 2.508758e-2 |
GO:0042108 | positive regulation of cytokine biosynthetic process | 2.545687e-2 |
GO:0010463 | mesenchymal cell proliferation | 2.557669e-2 |
GO:0007283 | spermatogenesis | 2.558908e-2 |
GO:0002637 | regulation of immunoglobulin production | 2.565368e-2 |
GO:0045061 | thymic T cell selection | 2.588868e-2 |
GO:0045995 | regulation of embryonic development | 2.598170e-2 |
GO:0002244 | hemopoietic progenitor cell differentiation | 2.612048e-2 |
GO:0009247 | glycolipid biosynthetic process | 2.625462e-2 |
GO:0006289 | nucleotide-excision repair | 2.627456e-2 |
GO:0008585 | female gonad development | 2.629096e-2 |
GO:0042113 | B cell activation | 2.638405e-2 |
GO:0016311 | dephosphorylation | 2.668800e-2 |
GO:0006564 | L-serine biosynthetic process | 2.690412e-2 |
GO:0030853 | negative regulation of granulocyte differentiation | 2.749083e-2 |
GO:0009064 | glutamine family amino acid metabolic process | 2.801430e-2 |
GO:0030029 | actin filament-based process | 2.805824e-2 |
GO:0051365 | cellular response to potassium ion starvation | 2.814159e-2 |
GO:0048007 | antigen processing and presentation, exogenous lipid antigen via MHC class Ib | 2.814159e-2 |
GO:0090037 | positive regulation of protein kinase C signaling cascade | 2.820989e-2 |
GO:0045589 | regulation of regulatory T cell differentiation | 2.820989e-2 |
GO:0007266 | Rho protein signal transduction | 2.876090e-2 |
GO:0001952 | regulation of cell-matrix adhesion | 2.908065e-2 |
GO:0008624 | induction of apoptosis by extracellular signals | 2.928109e-2 |
GO:0008334 | histone mRNA metabolic process | 2.937456e-2 |
GO:0035588 | G-protein coupled purinergic receptor signaling pathway | 2.954369e-2 |
GO:0046649 | lymphocyte activation | 2.963591e-2 |
GO:0001505 | regulation of neurotransmitter levels | 2.965356e-2 |
GO:0046826 | negative regulation of protein export from nucleus | 3.034437e-2 |
GO:0021501 | prechordal plate formation | 3.058150e-2 |
GO:0021547 | midbrain-hindbrain boundary initiation | 3.058150e-2 |
GO:0006541 | glutamine metabolic process | 3.062085e-2 |
GO:0044344 | cellular response to fibroblast growth factor stimulus | 3.068700e-2 |
GO:0007269 | neurotransmitter secretion | 3.069707e-2 |
GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress | 3.075068e-2 |
GO:0009067 | aspartate family amino acid biosynthetic process | 3.075068e-2 |
GO:0060197 | cloacal septation | 3.092068e-2 |
GO:0046689 | response to mercury ion | 3.128093e-2 |
GO:0010766 | negative regulation of sodium ion transport | 3.133288e-2 |
GO:0007067 | mitosis | 3.152934e-2 |
GO:0040012 | regulation of locomotion | 3.169659e-2 |
GO:0060323 | head morphogenesis | 3.169784e-2 |
GO:0001775 | cell activation | 3.181528e-2 |
GO:0022600 | digestive system process | 3.209628e-2 |
GO:0006807 | nitrogen compound metabolic process | 3.230533e-2 |
GO:0060897 | neural plate regionalization | 3.232552e-2 |
GO:0001539 | ciliary or flagellar motility | 3.234012e-2 |
GO:0007076 | mitotic chromosome condensation | 3.234012e-2 |
GO:0003148 | outflow tract septum morphogenesis | 3.234074e-2 |
GO:0048858 | cell projection morphogenesis | 3.295607e-2 |
GO:0006883 | cellular sodium ion homeostasis | 3.310186e-2 |
GO:0031959 | mineralocorticoid receptor signaling pathway | 3.310186e-2 |
GO:0003206 | cardiac chamber morphogenesis | 3.373226e-2 |
GO:0043170 | macromolecule metabolic process | 3.400202e-2 |
GO:0035088 | establishment or maintenance of apical/basal cell polarity | 3.401371e-2 |
GO:0006470 | protein dephosphorylation | 3.402199e-2 |
GO:0060968 | regulation of gene silencing | 3.441094e-2 |
GO:0051318 | G1 phase | 3.482038e-2 |
GO:0048485 | sympathetic nervous system development | 3.504811e-2 |
GO:0046365 | monosaccharide catabolic process | 3.521310e-2 |
GO:0015991 | ATP hydrolysis coupled proton transport | 3.543607e-2 |
GO:0045058 | T cell selection | 3.546705e-2 |
GO:0045938 | positive regulation of circadian sleep/wake cycle, sleep | 3.547457e-2 |
GO:0090169 | regulation of spindle assembly | 3.570042e-2 |
GO:0090234 | regulation of kinetochore assembly | 3.570042e-2 |
GO:0070166 | enamel mineralization | 3.570042e-2 |
GO:0043415 | positive regulation of skeletal muscle tissue regeneration | 3.570042e-2 |
GO:0002358 | B cell homeostatic proliferation | 3.570042e-2 |
GO:0035584 | calcium-mediated signaling using intracellular calcium source | 3.570042e-2 |
GO:0007167 | enzyme linked receptor protein signaling pathway | 3.593763e-2 |
GO:0030852 | regulation of granulocyte differentiation | 3.600659e-2 |
GO:0002087 | regulation of respiratory gaseous exchange by neurological system process | 3.616137e-2 |
GO:0030097 | hemopoiesis | 3.624870e-2 |
GO:0006707 | cholesterol catabolic process | 3.655705e-2 |
GO:0051329 | interphase of mitotic cell cycle | 3.693499e-2 |
GO:0046627 | negative regulation of insulin receptor signaling pathway | 3.711647e-2 |
GO:0033036 | macromolecule localization | 3.715659e-2 |
GO:0030036 | actin cytoskeleton organization | 3.735532e-2 |
GO:2000741 | positive regulation of mesenchymal stem cell differentiation | 3.765838e-2 |
GO:0045176 | apical protein localization | 3.765838e-2 |
GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway | 3.785347e-2 |
GO:0006796 | phosphate-containing compound metabolic process | 3.791086e-2 |
GO:0010506 | regulation of autophagy | 3.805025e-2 |
GO:0010970 | microtubule-based transport | 3.818126e-2 |
GO:0060005 | vestibular reflex | 3.827169e-2 |
GO:0045404 | positive regulation of interleukin-4 biosynthetic process | 3.827169e-2 |
GO:0032854 | positive regulation of Rap GTPase activity | 3.827169e-2 |
GO:0021847 | ventricular zone neuroblast division | 3.827169e-2 |
GO:0070104 | negative regulation of interleukin-6-mediated signaling pathway | 3.837495e-2 |
GO:2000744 | positive regulation of anterior head development | 3.837495e-2 |
GO:0060448 | dichotomous subdivision of terminal units involved in lung branching | 3.837495e-2 |
GO:0060028 | convergent extension involved in axis elongation | 3.837495e-2 |
GO:0021785 | branchiomotor neuron axon guidance | 3.837495e-2 |
GO:0032964 | collagen biosynthetic process | 3.839409e-2 |
GO:0010810 | regulation of cell-substrate adhesion | 3.862228e-2 |
GO:0045830 | positive regulation of isotype switching | 3.915737e-2 |
GO:0071103 | DNA conformation change | 3.919716e-2 |
GO:0048305 | immunoglobulin secretion | 3.991767e-2 |
GO:0021869 | forebrain ventricular zone progenitor cell division | 3.991767e-2 |
GO:0044237 | cellular metabolic process | 4.000334e-2 |
GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis | 4.012378e-2 |
GO:0032649 | regulation of interferon-gamma production | 4.017896e-2 |
GO:0051209 | release of sequestered calcium ion into cytosol | 4.074694e-2 |
GO:0022029 | telencephalon cell migration | 4.075536e-2 |
GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity | 4.112325e-2 |
GO:0032990 | cell part morphogenesis | 4.126386e-2 |
GO:0060613 | fat pad development | 4.143886e-2 |
GO:0045348 | positive regulation of MHC class II biosynthetic process | 4.143886e-2 |
GO:0008152 | metabolic process | 4.144618e-2 |
GO:0070208 | protein heterotrimerization | 4.150475e-2 |
GO:0032963 | collagen metabolic process | 4.172687e-2 |